Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects
Soon Sun Kim, Hyo Jung Cho, Hyun Ji Kim, et al.
Digestive and Liver Disease (2017) Vol. 50, Iss. 4, pp. 370-377
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye, Biyao Zou, Yee Hui Yeo, et al.
˜The œLancet. Gastroenterology & hepatology (2020) Vol. 5, Iss. 8, pp. 739-752
Closed Access | Times Cited: 686
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Michael H. Le, Yee Hui Yeo, Xiaohe Li, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 12, pp. 2809-2817.e28
Closed Access | Times Cited: 465
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Seong Hee Kang, Hye Won Lee, Jeong‐Ju Yoo, et al.
Clinical and Molecular Hepatology (2021) Vol. 27, Iss. 3, pp. 363-401
Open Access | Times Cited: 222
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
Soo Lim, Jin–Wook Kim, Giovanni Targher
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 7, pp. 500-514
Closed Access | Times Cited: 147
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis
Ansel Shao Pin Tang, Cheng Han Ng, Poh Hui Phang, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 7, pp. 1750-1760.e12
Closed Access | Times Cited: 75
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
Kai En Chan, Elden Yen Hng Ong, Charlotte Hui Chung, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 3, pp. 488-498.e14
Closed Access | Times Cited: 49
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis
Limin Cao, Yu An, Huiyuan Liu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk
Agostino Di Ciaula, Jacek Baj, Gabriella Garruti, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2648-2648
Open Access | Times Cited: 125
The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease
Yiwen Shi, Qianyi Wang, Yameng Sun, et al.
Journal of Clinical Gastroenterology (2019) Vol. 54, Iss. 4, pp. 378-387
Closed Access | Times Cited: 77
Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study
Yang Zou, Ling Zhong, Chong Hu, et al.
Lipids in Health and Disease (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 73
A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals
Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 36, Iss. 6, pp. 1497-1507
Open Access | Times Cited: 70
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
Amedeo Lonardo, Simonetta Lugari, Stefano Ballestri, et al.
Acta Diabetologica (2018) Vol. 56, Iss. 4, pp. 385-396
Closed Access | Times Cited: 80
Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study
Fengjiang Wei, Jiaxin Li, Chen Chen, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 58
Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis
Stefano Ciardullo, Guıdo Grassı, Giuseppe Mancia, et al.
European Journal of Gastroenterology & Hepatology (2021) Vol. 34, Iss. 4, pp. 365-371
Open Access | Times Cited: 51
Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus
Hyo Jung Cho, Sun Hyuk Hwang, Jong Ik Park, et al.
Gut and Liver (2019) Vol. 13, Iss. 4, pp. 440-449
Open Access | Times Cited: 51
Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD
Viera Kupčová, Michaela Fedelešová, J Bulas, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 19, pp. 3570-3570
Open Access | Times Cited: 49
Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults
Yanan Zhang, Qinqiu Wang, Yi-Shu Chen, et al.
International Journal of Endocrinology (2020) Vol. 2020, pp. 1-6
Open Access | Times Cited: 49
Epidemiology of nonalcoholic fatty liver disease in non‐obese populations: Meta‐analytic assessment of its prevalence, genetic, metabolic, and histological profiles
Ziyuan Zou, Vincent Wai‐Sun Wong, Jian‐Gao Fan
Journal of Digestive Diseases (2020) Vol. 21, Iss. 7, pp. 372-384
Closed Access | Times Cited: 43
Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
Lampros Chrysavgis, Eleftheria Ztriva, Άδωνις Πρωτοπαπάς, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 42, pp. 6514-6528
Open Access | Times Cited: 43
Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis.
Stefano Ciardullo, Guıdo Grassı, Giuseppe Mancia, et al.
PubMed Central (2022) Vol. 34, Iss. 4, pp. 365-371
Open Access | Times Cited: 22
Non-Alcoholic Fatty Liver Disease in Non-Obese Individuals: Prevalence, Pathogenesis and Treatment
Emilio Molina‐Molina, Marcin Krawczyk, Ewa Stachowska, et al.
Clinics and Research in Hepatology and Gastroenterology (2019) Vol. 43, Iss. 6, pp. 638-645
Closed Access | Times Cited: 39
Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes
Georgios Tsamos, Dimitra Vasdeki, Theocharis Koufakis, et al.
Metabolites (2023) Vol. 13, Iss. 4, pp. 517-517
Open Access | Times Cited: 11
Nonalcoholic fatty liver disease increases the risk of diabetes in young adults: A nationwide population-based study in Korea
Goh Eun Chung, Eun Ju Cho, Ji Won Yoon, et al.
Metabolism (2021) Vol. 123, pp. 154866-154866
Closed Access | Times Cited: 24
Nonalcoholic fatty liver disease and risk of incident hypertension
Stefano Ciardullo, Guıdo Grassı, Giuseppe Mancia, et al.
PubMed Central (2021) Vol. Publish Ahead of Print
Open Access | Times Cited: 23
Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study
Qian Zhang, Xiaoqian Ma, Jie Xing, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top